These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 34976222)
1. Tumor-specific activatable biopolymer nanoparticles stabilized by hydroxyethyl starch prodrug for self-amplified cooperative cancer therapy. Xiong Y; Wang Z; Wang Q; Deng Q; Chen J; Wei J; Yang X; Yang X; Li Z Theranostics; 2022; 12(2):944-962. PubMed ID: 34976222 [No Abstract] [Full Text] [Related]
2. A multivalent polyphenol-metal-nanoplatform for cascade amplified chemo-chemodynamic therapy. Li S; Zhao Y; Ma W; Wang D; Liu H; Wang W; Peng D; Yu CY; Wei H Acta Biomater; 2024 Jan; 173():389-402. PubMed ID: 37967695 [TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment-responsive polydopamine-based core/shell nanoplatform for synergetic theranostics. Chen Q; Shan X; Shi S; Jiang C; Li T; Wei S; Zhang X; Sun G; Liu J J Mater Chem B; 2020 May; 8(18):4056-4066. PubMed ID: 32270145 [TBL] [Abstract][Full Text] [Related]
4. Multifunctional MnO Wang Q; Qu B; Li J; Liu Y; Dong J; Peng X; Zhang R ACS Appl Mater Interfaces; 2022 Feb; 14(4):4980-4994. PubMed ID: 35050589 [TBL] [Abstract][Full Text] [Related]
5. Tumor Microenvironment-Activated Theranostics Nanozymes for Fluorescence Imaging and Enhanced Chemo-Chemodynamic Therapy of Tumors. Zhao DH; Li CQ; Hou XL; Xie XT; Zhang B; Wu GY; Jin F; Zhao YD; Liu B ACS Appl Mater Interfaces; 2021 Dec; 13(47):55780-55789. PubMed ID: 34787410 [TBL] [Abstract][Full Text] [Related]
6. Cu-Chelated polydopamine nanoparticles as a photothermal medium and "immunogenic cell death" inducer for combined tumor therapy. Xu N; Hu A; Pu X; Wang J; Liao X; Huang Z; Yin G J Mater Chem B; 2022 Apr; 10(16):3104-3118. PubMed ID: 35348176 [TBL] [Abstract][Full Text] [Related]
7. Mutual Benefit between Cu(II) and Polydopamine for Improving Photothermal-Chemodynamic Therapy. Zhang WX; Hao YN; Gao YR; Shu Y; Wang JH ACS Appl Mater Interfaces; 2021 Aug; 13(32):38127-38137. PubMed ID: 34347422 [TBL] [Abstract][Full Text] [Related]
8. Copper-based theranostic nanocatalysts for synergetic photothermal-chemodynamic therapy. Zuo W; Fan Z; Chen L; Liu J; Wan Z; Xiao Z; Chen W; Wu L; Chen D; Zhu X Acta Biomater; 2022 Jul; 147():258-269. PubMed ID: 35605954 [TBL] [Abstract][Full Text] [Related]
9. H Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485 [TBL] [Abstract][Full Text] [Related]
10. NIR-II-driven and glutathione depletion-enhanced hypoxia-irrelevant free radical nanogenerator for combined cancer therapy. Zhang L; Fan Y; Yang Z; Yang M; Wong CY J Nanobiotechnology; 2021 Sep; 19(1):265. PubMed ID: 34488803 [TBL] [Abstract][Full Text] [Related]
11. A Simple Glutathione-Responsive Turn-On Theranostic Nanoparticle for Dual-Modal Imaging and Chemo-Photothermal Combination Therapy. Li Y; Wu Y; Chen J; Wan J; Xiao C; Guan J; Song X; Li S; Zhang M; Cui H; Li T; Yang X; Li Z; Yang X Nano Lett; 2019 Aug; 19(8):5806-5817. PubMed ID: 31331172 [TBL] [Abstract][Full Text] [Related]
12. Biomimetic nanoplatform with H Fu LH; Wu XY; He J; Qi C; Lin J; Huang P Acta Biomater; 2023 May; 162():44-56. PubMed ID: 36934891 [TBL] [Abstract][Full Text] [Related]
13. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy. Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515 [TBL] [Abstract][Full Text] [Related]
14. Facile Synthesis of Fe Qi C; Wang W; Wang P; Cheng H; Wang X; Gong B; Xie A; Shen Y Molecules; 2022 Jun; 27(13):. PubMed ID: 35807249 [TBL] [Abstract][Full Text] [Related]
15. pH-Activatable copper-axitinib coordinated multifunctional nanoparticles for synergistic chemo-chemodynamic therapy against aggressive cancers. Ji M; Liu H; Wang H; Liang X; Wei M; Shi D; Gou J; Yin T; He H; Tang X; Zhang Y Biomater Sci; 2023 Sep; 11(18):6267-6279. PubMed ID: 37545202 [TBL] [Abstract][Full Text] [Related]
16. Photothermal nanozymes to self-augment combination cancer therapy by dual-glutathione depletion and hyperthermia/acidity-activated hydroxyl radical generation. Wang TH; Shen MY; Yeh NT; Chen YH; Hsu TC; Chin HY; Wu YT; Tzang BS; Chiang WH J Colloid Interface Sci; 2023 Nov; 650(Pt B):1698-1714. PubMed ID: 37499626 [TBL] [Abstract][Full Text] [Related]
17. Novel Tumor-Microenvironment-Based Sequential Catalytic Therapy by Fe(II)-Engineered Polydopamine Nanoparticles. Zhu Y; Xin N; Qiao Z; Chen S; Zeng L; Zhang Y; Wei D; Sun J; Fan H ACS Appl Mater Interfaces; 2019 Nov; 11(46):43018-43030. PubMed ID: 31660723 [TBL] [Abstract][Full Text] [Related]
18. Cu-MOF chemodynamic nanoplatform via modulating glutathione and H Tian H; Zhang M; Jin G; Jiang Y; Luan Y J Colloid Interface Sci; 2021 Apr; 587():358-366. PubMed ID: 33360905 [TBL] [Abstract][Full Text] [Related]
19. Bovine serum albumin-templated nanoplatform for magnetic resonance imaging-guided chemodynamic therapy. Tang W; Gao H; Ni D; Wang Q; Gu B; He X; Peng W J Nanobiotechnology; 2019 May; 17(1):68. PubMed ID: 31109332 [TBL] [Abstract][Full Text] [Related]
20. A glutathione-depleting chemodynamic therapy agent with photothermal and photoacoustic properties for tumor theranostics. Liu F; Lin L; Sheng S; Xu C; Wang Y; Zhang Y; Wang D; Wu J; Li Y; Tian H; Chen X Nanoscale; 2020 Jan; 12(3):1349-1355. PubMed ID: 31913380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]